BRC news

BRC latest news

This displays the latest news items related to the Biomedical Research Centre.

GOSH joins groundbreaking genetic study into COVID-19

Great Ormond Street Hospital (GOSH) is recruiting COVID-19 patients to participate in a new nationwide study looking at why some people are more severely affected by the virus than others, as part of a partnership between the GenOMICC Study Consortium (led by the University of Edinburgh) and Genomics England.

Genetic study of over 1,000 people sheds new light on immune-system disorders

Whole Genome Sequencing (WGS) can provide a more accurate diagnosis for patients with missing or poorly functioning immune systems, while providing new insight into complex genetic causes, according to results of a new international study involving researchers from the UCL Great Ormond Street Institute of Child Health (ICH).

Five COVID-19 questions we’re trying to answer

Our army of researchers at GOSH and the UCL Great Ormond Street Institute of Child Health (ICH) are supporting scientific studies aimed at understanding, tracking and even stopping COVID-19. Several studies employ the expertise of intensive care researcher Professor Mark Peters, pictured above in 2017.

Researchers unlock new treatment options for babies with brain tumours

An international collaboration including researchers from the UCL Great Ormond Street Institute of Child Health (ICH) has found brain tumours in babies are biologically different to those in older children and could be targeted by existing medications.

Meet the GOSH brain tumour trials team

Diagnosis with a brain tumour can bring family life to a standstill in the worst possible way. But it also sparks an immediate flurry of activity, as a multi-disciplinary GOSH team springs into action around the child and their family. From radiology and genetics to nursing and psychology, these experts provide support and care at every stage of the child’s journey, as well as supporting vital research to find new treatments and cures. We found out more from three members of the expert brain tumour clinical trials team.

GOSH research brings Duchenne muscular dystrophy drug one step closer to UK patients

A drug that ‘skips over’ a genetic fault responsible for the fatal muscle-wasting condition Duchenne muscular dystrophy (DMD) has shown promising results in an international trial led by Great Ormond Street Hospital (GOSH).